30 related articles for article (PubMed ID: 1667978)
1. Tubulin pools in human erythrocytes: altered distribution in hypertensive patients affects Na+, K+-ATPase activity.
Amaiden MR; Santander VS; Monesterolo NE; Campetelli AN; Rivelli JF; Previtali G; Arce CA; Casale CH
Cell Mol Life Sci; 2011 May; 68(10):1755-68. PubMed ID: 20953891
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte and plasma Ca2+, Mg2+ and cell membrane adenosine triphosphatase activity in patients with essential hypertension.
Fu Y; Wang S; Lu Z; Li H; Li S
Chin Med J (Engl); 1998 Feb; 111(2):147-9. PubMed ID: 10374376
[TBL] [Abstract][Full Text] [Related]
3. Alteration of erythrocyte membrane Na, K-ATPase in children with borderline or essential hypertension.
Stojadinovic ND; Petronijević MR; Pavićević MH; Mrsulja BB; Kostić MM
Cell Biochem Funct; 1996 Jun; 14(2):79-87. PubMed ID: 8640956
[TBL] [Abstract][Full Text] [Related]
4. [Activity of transporting ATPase and functional properties of blood cells in patients with hypertension].
Gurevich VS; Moiseeva OM; Mikhaĭlova IA; Roĭ AIu
Vopr Med Khim; 1993; 39(1):32-4. PubMed ID: 8388596
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte membrane ouabain-sensitive Na+, K(+)-ATPase of hypertensive Nigerians.
Olorunsogo OO; Lawal SO; Falase AO; Okunade WG
Afr J Med Med Sci; 1991 Jun; 20(2):75-82. PubMed ID: 1652190
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte calcium-stimulated, magnesium-activated adenosine 5'-triphosphatase activity in essential hypertension.
Adeoya AS; Bing RF; Norman RI
J Hypertens; 1992 Jul; 10(7):651-6. PubMed ID: 1321192
[TBL] [Abstract][Full Text] [Related]
7. [Various properties of the Na+, K(+)-ATPase and the Mg (2+)-ATPase in erythrocytes from normotensive and hypertensive subjects].
Canestrari F; Galli F; Gheller G; De Crescentini S; Biagiarelli B
Boll Soc Ital Biol Sper; 1991 Jul; 67(7):659-66. PubMed ID: 1667978
[TBL] [Abstract][Full Text] [Related]
8. [Erythrocyte (Na(+)-K+) ATPase activity].
Mimura M; Kanatsuka A
Nihon Rinsho; 1998 Jan; 56 Suppl 3():169-74. PubMed ID: 9513409
[No Abstract] [Full Text] [Related]
9. [Na,K-ATPase in human red blood cell membranes].
Matsui S; Teraoka K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():772-6. PubMed ID: 15658447
[No Abstract] [Full Text] [Related]
10. Regulation of Na+/K+-ATPase by Estradiol and IGF-1 in Cardio-Metabolic Diseases.
Obradovic M; Stanimirovic J; Panic A; Bogdanovic N; Sudar-Milovanovic E; Cenic-Milosevic D; Isenovic ER
Curr Pharm Des; 2017; 23(10):1551-1561. PubMed ID: 28164755
[TBL] [Abstract][Full Text] [Related]
11. Is a circulating sodium transport inhibitor involved in the pathogenesis of essential hypertension?
MacGregor GA; de Wardener HE
Clin Exp Hypertens (1978); 1981; 3(4):815-30. PubMed ID: 6271510
[TBL] [Abstract][Full Text] [Related]
12. The role of Na,K-ATPase inhibitors in hypertension and end-stage renal disease.
Bargman JM
Perit Dial Int; 1997; 17(6):536-40. PubMed ID: 9655151
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
